Episode

Closing the Gap Between IBD Therapies and Patient Outcomes, With David Rubin, MD

Podcast
HCPLive Podcasts
Published
May 6, 2026
Duration seconds
660
Processing state
not_requested
Canonical source
https://audioboom.com/posts/8900313
Audio
https://audioboom.com/posts/8900313.mp3?modified=1778101649&sid=5004077&source=rss
JSON
/v1/public/podcasts/hcplive-podcasts-19526/episodes/closing-the-gap-between-ibd-therapies-and-patient-outcomes-with-david-rubin-md
Markdown
/podcast/hcplive-podcasts-19526/closing-the-gap-between-ibd-therapies-and-patient-outcomes-with-david-rubin-md.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/hcplive-podcasts-19526/episodes/closing-the-gap-between-ibd-therapies-and-patient-outcomes-with-david-rubin-md/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/hcplive-podcasts-19526/closing-the-gap-between-ibd-therapies-and-patient-outcomes-with-david-rubin-md.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Despite more than 14 approved therapies for Crohn's disease and ulcerative colitis, many patients still aren't reaching remission. At DDW 2026, David Rubin, MD, of the University of Chicago Medicine explains why the problem isn't the drugs — it's how and when we use them. He covers early treatment strategies, treat-to-target monitoring, the induction pitfall, and when to switch mechanisms rather than cycling within class. Read more: https://www.hcplive.com/view/closing-the-gap-between-ibd-therapies-and-patient-outcomes-with-david-rubin-md